False Positive Tests for Anti-Hepatitis C Antibodies and the Problem of Notifying Blood Donors | Zendy

SHULAMITH BAR-SHANY | Zendy; Manfred S. Green | Zendy; Eilat Shinar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

False Positive Tests for Anti-Hepatitis C Antibodies and the Problem of Notifying Blood Donors

Author(s) -

SHULAMITH BAR-SHANY,

Manfred S. Green,

Eilat Shinar

Publication year - 1996

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/25.3.674

Subject(s) - antibody , medicine , immunology , hepatitis c , hepatitis c virus , blood donations , false positive paradox , immunoassay , blood transfusion , gastroenterology , virus , machine learning , computer science

All donated blood in Israel is tested for anti-hepatitis C virus (HCV) antibodies by enzyme immunoassay (EIA) and donors are notified of the result. There is evidence that at low antibody titres, the percentage of false positives may be high, with consequent labelling of healthy people as being infected with HCV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research